Guide · Updated April 2026
Compounded GLP-1 Quality: How to Verify Your Pharmacy
Compounded semaglutide and tirzepatide (GLP-1 receptor agonists sold as brand-name Wegovy, Ozempic, Mounjaro, and Zepbound) are available from compounding pharmacies at $149 to $299 per month. Quality varies widely. FDA-registered 503B outsourcing facilities follow cGMP standards and provide batch-level HPLC potency testing, while state-regulated 503A pharmacies have no federal testing mandate. Patients should verify pharmacy type, accreditation, and batch testing before starting treatment.
I switched from brand-name Mounjaro to a compounded tirzepatide product for two months in late 2025 to test the experience firsthand. The medication worked. My DEXA results stayed consistent. But the process of figuring out whether the pharmacy behind my prescription was legitimate took more research than I expected. Most patients never do that research. This guide walks through exactly what to look for and what to avoid.
The compounded GLP-1 pharmacy quality question matters because not every pharmacy producing these medications operates at the same standard. Some run batch-level potency testing on every production run. Others do not. And in a market where Novo Nordisk has claimed impurity rates as high as 86% in tested samples (a figure that deserves scrutiny given their financial interest in discrediting compounders), patients need a way to evaluate quality for themselves.
Two Types of Compounding Pharmacies (and Why It Matters)
The single most important thing you can verify about your compounded GLP-1 is what type of pharmacy produces it. Under the Federal Food, Drug, and Cosmetic Act, there are two categories of compounding pharmacies, and the difference in oversight is significant.
503A pharmacies are traditional compounding pharmacies. They fill individual prescriptions for specific patients. They are regulated primarily by state boards of pharmacy, not by the FDA. Quality standards, testing requirements, and inspection frequency vary from state to state. Some states have strong compounding regulations. Others have minimal oversight.
503B outsourcing facilities operate at a larger scale and are registered with the FDA. They follow Current Good Manufacturing Practices (cGMP), the same framework that governs pharmaceutical manufacturing. They undergo FDA inspections. They can produce medications in bulk and distribute to healthcare providers and facilities.
If you are going to use compounded semaglutide or tirzepatide, a 503B facility provides a meaningfully higher quality standard than most 503A pharmacies. This is not a subtle difference.
For context on the legal picture for compounded GLP-1s in 2026, that guide covers the shortage list timeline and enforcement actions.
The Quality Gap: What Testing Actually Looks Like
Here is what separates a high-quality compounding operation from a low-quality one.
High-Performance Liquid Chromatography (HPLC)
HPLC is the gold standard for verifying that a compounded medication contains the correct amount of active ingredient. The test measures potency (how much semaglutide or tirzepatide is actually in the vial) and identifies impurities or degradation products.
A 503B facility like Belmar Pharmacy (used by MEDVi) performs HPLC testing on every production batch. The results confirm that each vial contains the labeled dose within acceptable variance (typically plus or minus 10% of the stated potency).
A 503A pharmacy may or may not perform HPLC testing. Many rely on certificates of analysis from their raw ingredient suppliers, which verify the quality of the input material but not the finished product. This is a meaningful gap. A raw ingredient can be 99% pure and still end up in an improperly formulated final product if the pharmacy’s compounding process introduces errors.
Sterility Testing
Injectable medications need to be sterile. Contaminated injectables can cause infections, abscesses, and in rare cases, life-threatening sepsis. The 2012 New England Compounding Center disaster (a fungal meningitis outbreak that killed 76 people from contaminated steroid injections) is the extreme example of what happens when compounding sterility fails.
503B facilities are required to perform sterility testing under USP Chapter 797 standards. 503A pharmacies should follow USP 797 as well, but enforcement depends on the state.
Beyond-Use Dating
Beyond-use dates (BUDs) tell you how long a compounded medication remains stable and potent after preparation. A pharmacy that has conducted stability studies on its formulations can assign longer, evidence-based BUDs. A pharmacy without stability data typically defaults to conservative USP guidelines.
This matters practically because a compounded GLP-1 vial that degrades faster than expected means you are injecting less active medication than you think. If your weight loss stalls unexpectedly on a compounded product, potency degradation is one possible explanation.
Red Flags: When to Walk Away
Not every compounded GLP-1 provider is equal. Through reviewing 73 telehealth providers for ClearMetabolic, I have seen patterns that separate trustworthy operations from questionable ones.
Pricing Below $100 Per Month
Compounded semaglutide typically costs $149 to $199 per month from reputable providers. Compounded tirzepatide runs $179 to $499 depending on dose. If you see prices significantly below these ranges, ask where the savings come from. Sometimes it is a legitimate introductory offer. Sometimes it reflects cut corners on testing, ingredient sourcing, or pharmacy standards.
No Pharmacy Name Disclosed
A legitimate telehealth provider should tell you which compounding pharmacy fills your prescription. If a provider refuses to name the pharmacy or gives vague answers (“we work with multiple FDA-registered pharmacies”), that is a problem. You have a right to know who makes your medication.
Claims of “FDA-Approved” Compounded Medication
No compounded medication is FDA-approved as a finished product. The active ingredient (semaglutide or tirzepatide) is FDA-approved. The specific compounded formulation is not. Any provider claiming their compounded product is “FDA-approved” is either confused or deliberately misleading you. For a deeper look at the differences between compounded and brand-name GLP-1s, that guide breaks it down.
No Doctor Consultation
Compounded GLP-1s are prescription medications. A provider that ships them without a physician or nurse practitioner evaluation is operating outside legal boundaries. The consultation does not need to be in-person (telehealth is fine), but it needs to happen.
Extremely Long Supply Shipments
Getting a 90-day supply of a compounded injectable at once raises storage and stability questions. Most reputable providers ship 30-day supplies. Some offer 60-day shipments with clear storage instructions. A provider shipping 90+ day supplies of a peptide medication without stability data to support that timeline is taking a risk with your medication’s potency.
Compare GLP-1 providers
Browse Provider Directory →Your Verification Checklist
Before filling a compounded GLP-1 prescription, run through these steps. This takes about 15 minutes and can save you from wasting money on a substandard product.
Step 1: Identify the Pharmacy
Ask your telehealth provider: “Which compounding pharmacy fills my prescription?” Get the full name and location.
Step 2: Check Pharmacy Type and Registration
- For 503B facilities: Search the FDA’s Registered Outsourcing Facilities list to confirm registration. Check for any recent FDA warning letters or inspection findings.
- For 503A pharmacies: Verify the pharmacy holds an active license with its state board of pharmacy. Check if the pharmacy holds PCAB accreditation (Pharmacy Compounding Accreditation Board), a voluntary standard that indicates higher quality practices.
Step 3: Ask About Testing
Request answers to these specific questions:
- Do you perform HPLC potency testing on finished products (not just raw ingredients)?
- How often? Every batch, or periodic sampling?
- Can you provide a certificate of analysis for the batch my medication comes from?
- What sterility testing protocol do you follow?
- What are the beyond-use dates for your GLP-1 formulations, and are they based on stability studies?
A quality pharmacy will answer these questions directly. A pharmacy that dodges them or does not understand the questions is not where you want your injectable medication coming from.
Step 4: Verify the Provider’s Medical Process
Confirm that:
- A licensed physician, NP, or PA reviews your medical history before prescribing
- Lab work is required (at minimum, basic metabolic panel and A1C)
- Follow-up appointments are scheduled (not just a one-time prescription)
- The provider has a process for reporting adverse events
Compounded GLP-1 Pharmacy Quality Comparison
Here is how different pharmacy types and standards stack up:
| Quality Indicator | 503B Facility (Best) | 503A with PCAB | 503A without PCAB |
|---|---|---|---|
| Federal regulation | FDA-registered | State board only | State board only |
| cGMP compliance | Required | Voluntary (PCAB standard) | Not required |
| HPLC batch testing | Standard practice | Often included | Varies widely |
| Sterility testing | USP 797 required | USP 797 (PCAB standard) | State-dependent |
| FDA inspection | Yes | No (PCAB audits instead) | No |
| Stability studies | Typically conducted | Sometimes | Rarely |
| Typical cost | $199 to $299/mo | $149 to $249/mo | $129 to $199/mo |
| Example providers | MEDVi, Henry Meds | Varies | Varies |
The price difference between pharmacy tiers is real but modest. Paying an extra $50 per month for a 503B-sourced product versus the cheapest 503A option is a reasonable trade for verified potency and sterility. For a full pricing breakdown across providers, see our cheapest GLP-1 guide.
What the Clinical Data Tells Us About Compounded Quality
No large-scale clinical trials have been conducted specifically on compounded semaglutide or tirzepatide. All the major efficacy and safety data comes from brand-name products.
The SURMOUNT-1 trial (NEJM, July 2022) studied brand-name tirzepatide in 2,539 adults with obesity and found 22.5% mean weight loss at the 15mg dose over 72 weeks. The STEP 1 trial (NEJM, February 2021) found 14.9% weight loss with brand-name semaglutide 2.4mg over 68 weeks. These results were achieved with pharmaceutical-grade medications produced under the strictest manufacturing conditions.
When you use a compounded version, you are making the pharmacological assumption that the same active ingredient at the same dose produces the same effect. This is generally valid. But “generally valid” depends on the compounded product actually containing the correct dose at the correct potency. That is exactly why HPLC batch testing matters.
I tracked my own results on compounded tirzepatide against my prior brand-name Mounjaro data. Over the two months I used the compounded product, my weight trajectory and DEXA scan results were consistent with what I had seen on brand-name. But I specifically chose a provider that uses a 503B pharmacy with published batch testing. I would not have been as confident with an untested 503A product.
What Novo Nordisk and Eli Lilly Say (and What to Make of It)
Both manufacturers have been vocal opponents of compounded GLP-1 medications. Novo Nordisk has published testing data claiming to find high impurity rates in compounded semaglutide samples. Eli Lilly has pursued legal action against compounding pharmacies producing tirzepatide.
These companies have legitimate points about quality control. They also have billions of dollars in revenue at stake. Brand-name Wegovy costs $1,349 per month at list price, and every patient using a $149 compounded alternative is a lost sale.
The truth sits in the middle. Some compounded products are genuinely substandard. Others, particularly from 503B facilities with rigorous testing, are likely comparable in quality to brand-name products. The manufacturer testing that found high impurity rates did not distinguish between pharmacy types, making their headline numbers less useful than they appear.
If you want to eliminate the quality question entirely, brand-name options have become more affordable. Zepbound vials from LillyDirect start at $349 per month for the 2.5mg dose (as of April 2026). The Wegovy oral pill launched at $299 per month. These narrow the price gap with compounded versions while offering full FDA oversight.
What to Do If Your Compounding Pharmacy Shuts Down
The compounded GLP-1 market has already seen pharmacy closures and FDA enforcement actions. If your pharmacy closes or your provider loses access to their compounding partner, you have options. Our guide on what to do when your compounding pharmacy shuts down covers the transition process in detail.
The short version: do not stop your medication abruptly. GLP-1 receptor agonists can cause rebound appetite and weight regain when discontinued suddenly. Work with your prescriber to find an alternative source or transition to a brand-name product within the same dose range.
Bottom Line
Compounded GLP-1 quality ranges from excellent to questionable, and the difference comes down to the pharmacy behind your prescription. A 503B outsourcing facility with HPLC batch testing and FDA registration provides a standard close to brand-name manufacturing. A 503A pharmacy without third-party accreditation or finished-product testing is a bigger gamble.
Before you fill a compounded semaglutide or tirzepatide prescription, spend 15 minutes running through the verification checklist above. Know your pharmacy’s name, type, and testing practices. If a provider will not tell you which pharmacy makes your medication, find a different provider.
For patients who want to compare providers that use verified compounding pharmacies, our provider directory includes pharmacy sourcing details where available.
FAQ
How do I know if my compounded GLP-1 is safe?
Ask your provider which pharmacy compounds the medication. Verify that the pharmacy is either an FDA-registered 503B outsourcing facility or a PCAB-accredited 503A pharmacy. Request a certificate of analysis showing HPLC potency testing results for your medication batch. A legitimate pharmacy will provide this information.
What is the difference between a 503A and 503B compounding pharmacy?
503B outsourcing facilities are FDA-registered, follow Current Good Manufacturing Practices (cGMP), and undergo federal inspections. They can produce medications in bulk. 503A pharmacies are traditional compounding pharmacies regulated by state boards, filling individual prescriptions. 503B facilities generally maintain higher quality standards for GLP-1 compounding.
Can I get batch testing results for my compounded semaglutide?
Yes. Ask your provider or the compounding pharmacy directly for a certificate of analysis (COA) for the batch your medication was produced in. A quality pharmacy will have HPLC potency testing, sterility testing, and endotoxin testing results available. If the pharmacy cannot or will not provide these, consider switching to a provider that uses a more transparent pharmacy.
Are compounded GLP-1 medications as effective as brand-name?
If the compounded medication contains the correct dose of the active ingredient at the labeled potency, it should produce comparable effects. All major clinical trial data (SURMOUNT-1 for tirzepatide, STEP 1 for semaglutide) used brand-name products. Compounded products from 503B facilities with verified batch testing are most likely to match brand-name efficacy.
What should I do if my compounded GLP-1 seems less effective than expected?
First, verify the dose and confirm proper storage (most compounded GLP-1s require refrigeration). If storage and dosing are correct, ask your pharmacy for batch testing results to check potency. Consider switching to a provider that uses a 503B facility with HPLC testing. If issues persist, talk to your prescriber about transitioning to a brand-name product.
Related
Guides:
- Compounded vs Brand-Name GLP-1 · Is Compounded Semaglutide Legal in 2026? · Compounding Pharmacy Closed?
Provider Reviews: MEDVi · Henry Meds · Hims
Compare: All Providers · Best GLP-1 Programs · Cheapest GLP-1 Online